Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;16(12):1547-51.
doi: 10.1016/j.jocn.2009.05.003. Epub 2009 Sep 30.

A systematic review of intracranial chondrosarcoma and survival

Orin G Bloch  1 , Brian J Jian, Isaac Yang, Seunggu J Han, Derick Aranda, Brian J Ahn, Andrew T Parsa
Affiliations

A systematic review of intracranial chondrosarcoma and survival

Orin G Bloch et al. J Clin Neurosci. 2009 Dec.

Abstract

Most data regarding survival in patients with chondrosarcoma are limited to case studies and small series performed at single institutions. A systematic review was performed to study the relationship between potential prognostic factors and survival. The survival rates were analyzed according to modality of treatment, treatment history, histological subtype, and histological grade. A total of 560 patients with intracranial chondrosarcoma were analyzed. Median follow-up time was 60 months. The 5-year mortality among all patients was 11.5% with median survival of 24 months. Mortality at 5 years was significantly greater for patients with tumors of higher grade, or of the mesenchymal subtype, or who had received surgical resection alone. The results of our systematic review provide useful data in predicting survival among intracranial chondrosarcoma patients.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The effect of treatment on the 5-year mortality rate from chondrosarcoma showing that mortality was higher in patients who had undergone surgery only.
Fig. 2
Fig. 2
The effect of previous treatment on the 5-year mortality rate from chondrosarcoma showing that treatment history had no effect.
Fig. 3
Fig. 3
The effect of histological subtype on the 5-year mortality rate showing that mortality was lower among patients with the conventional chondrosarcoma subtype.
Fig. 4
Fig. 4
The effect of histological grade on the 5-year mortality rate showing that mortality increased with a corresponding increase in World Health Organization grade (I–III) chondrosarcoma.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cianfriglia F, Pompili A, Occhipinti E. Intracranial malignant cartilaginous tumours. Report of two cases and review of literature. Acta Neurochir (Wien) 1978;45:163–175. - PubMed
    1. Dorfman H. Mosby; Bone Tumors. St. Louis: 1998.
    1. Korten AG, ter Berg HJ, Spincemaille GH, van der Laan RT, Van de Wel AM. Intracranial chondrosarcoma: review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry. 1998;65(1):88–92. - PMC - PubMed
    1. Austin-Seymour M, Munzenrider J, Goitein M, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg. 1989;70(1):13–17. - PubMed
    1. Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery. 1995;36(5):887–896. discussion 896-887. - PubMed

Publication types